These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25038737)

  • 1. Gut microbial translocation in the pathogenesis of systemic inflammation in patients with end-stage renal disease.
    Vaziri ND
    Dig Dis Sci; 2014 Sep; 59(9):2020-2. PubMed ID: 25038737
    [No Abstract]   [Full Text] [Related]  

  • 2. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.
    Dinh DM; Volpe GE; Duffalo C; Bhalchandra S; Tai AK; Kane AV; Wanke CA; Ward HD
    J Infect Dis; 2015 Jan; 211(1):19-27. PubMed ID: 25057045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut bacterial translocation may aggravate microinflammation in hemodialysis patients.
    Shi K; Wang F; Jiang H; Liu H; Wei M; Wang Z; Xie L
    Dig Dis Sci; 2014 Sep; 59(9):2109-17. PubMed ID: 24828917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients.
    Wang F; Jiang H; Shi K; Ren Y; Zhang P; Cheng S
    Nephrology (Carlton); 2012 Nov; 17(8):733-8. PubMed ID: 22817644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.
    Giannelli V; Di Gregorio V; Iebba V; Giusto M; Schippa S; Merli M; Thalheimer U
    World J Gastroenterol; 2014 Dec; 20(45):16795-810. PubMed ID: 25492994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease.
    Anders HJ; Andersen K; Stecher B
    Kidney Int; 2013 Jun; 83(6):1010-6. PubMed ID: 23325079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between inflammatory markers and microbial translocation in patients with human immunodeficiency virus infection taking antiretroviral treatment].
    Reus Bañuls S; Portilla Sogorb J; Sanchez-Paya J; Boix Martínez V; Giner Oncina L; Frances R; Such J; Merino Lucas E; Gimeno Gascón A
    Med Clin (Barc); 2014 Jan; 142(2):47-52. PubMed ID: 24120098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation.
    Andersen K; Kesper MS; Marschner JA; Konrad L; Ryu M; Kumar Vr S; Kulkarni OP; Mulay SR; Romoli S; Demleitner J; Schiller P; Dietrich A; Müller S; Gross O; Ruscheweyh HJ; Huson DH; Stecher B; Anders HJ
    J Am Soc Nephrol; 2017 Jan; 28(1):76-83. PubMed ID: 27151924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Micro-inflammation and digestive bacterial translocation in chronic kidney disease].
    Olivier V; Dunyach-Remy C; Lavigne JP; Moranne O
    Nephrol Ther; 2018 May; 14(3):135-141. PubMed ID: 29295767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial DNA translocation holds increased insulin resistance and systemic inflammatory levels in morbid obese patients.
    Ortiz S; Zapater P; Estrada JL; Enriquez P; Rey M; Abad A; Such J; Lluis F; Francés R
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2575-83. PubMed ID: 24735424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome, obesity-related comorbidities, and low-grade chronic inflammation.
    Tarantino G
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2343-6. PubMed ID: 25003243
    [No Abstract]   [Full Text] [Related]  

  • 12. New Insights on End-Stage Renal Disease and Healthy Individual Gut Bacterial Translocation: Different Carbon Composition of Lipopolysaccharides and Different Impact on Monocyte Inflammatory Response.
    Adda-Rezig H; Carron C; Pais de Barros JP; Choubley H; Charron É; Rérole AL; Laheurte C; Louvat P; Gaiffe É; Simula-Faivre D; Deckert V; Lagrost L; Saas P; Ducloux D; Bamoulid J
    Front Immunol; 2021; 12():658404. PubMed ID: 34163471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota: Anti-cancer therapies affected by gut microbiota.
    Greenhill C
    Nat Rev Gastroenterol Hepatol; 2014 Jan; 11(1):1. PubMed ID: 24322902
    [No Abstract]   [Full Text] [Related]  

  • 14. End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal Transplantation.
    Carron C; Pais de Barros JP; Gaiffe E; Deckert V; Adda-Rezig H; Roubiou C; Laheurte C; Masson D; Simula-Faivre D; Louvat P; Moulin B; Frimat L; Rieu P; Mousson C; Durrbach A; Heng AE; Saas P; Ducloux D; Lagrost L; Bamoulid J
    Front Immunol; 2019; 10():1630. PubMed ID: 31474974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is it posible to reduce the human immunodeficiency virus-associated chronic inflammation?].
    Rocafort M; Paredes R
    Med Clin (Barc); 2014 Jan; 142(2):64-6. PubMed ID: 24216015
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial.
    Kimer N; Pedersen JS; Tavenier J; Christensen JE; Busk TM; Hobolth L; Krag A; Al-Soud WA; Mortensen MS; Sørensen SJ; Møller S; Bendtsen F;
    J Gastroenterol Hepatol; 2018 Jan; 33(1):307-314. PubMed ID: 28671712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current view on gut microbiota].
    Bourlioux P
    Ann Pharm Fr; 2014 Jan; 72(1):15-21. PubMed ID: 24438664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.
    Villar-García J; Güerri-Fernández R; Moya A; González A; Hernández JJ; Lerma E; Guelar A; Sorli L; Horcajada JP; Artacho A; D Auria G; Knobel H
    PLoS One; 2017; 12(4):e0173802. PubMed ID: 28388647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual of bacterial DNA in hemodialyzers: the proof of subclinical infection sustaining chronic inflammation.
    De Cal M; Cazzavillan S; Rassu M; Ronco C
    Int J Artif Organs; 2008 May; 31(5):395-404. PubMed ID: 18609512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.